A Study to Evaluate Safety and Tolerability of IV or SC Dose of MEDI-545 in Patients With Systemic Lupus Erythematosus.
Clinical trial NCT01031836 · COMPLETED
Trial details
- NCT number
- NCT01031836
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-25
- Primary completion
- 2012-11-07
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.